Transtema: Brighter Times Ahead

Research Update

2024-08-16

06:45

Redeye maintains a positive view of Transtema following a Q2 beating our expectations. While the Q2 numbers were on the soft side as expected (yet better than expected), the most important takeaway is that the worst likely is over, and Transtema enters 2025 with a solid order backlog. Although we somewhat lower our expectations in Norway, we retain our positive view of 2025.

Fredrik Nilsson

Encouraging Q/Q Improvement – Yet Soft Q2

Sales was SEK609m (713) and came in 9% above our forecast of SEK556m. Organic growth was -14.6%, compared to -27% in Q1. EBITA was SEK19m (14). Our forecast was SEK 16m. The EBITA margin was 3.1%, compared to 3.0% (adjusted) in Q2 2023 and 0.6% (adjusted) in Q1 2024, and above our forecast of 2.8%. While still substantially below the 7% margin target (which is a very high level in this sector), we are encouraged to see margins improving and seemingly bottoming out.

Deal Inflow Remained Strong

Transtema continues to see a strong deal flow, especially in the Swedish market – including the SEK500m with a Swedish telecommunication equipment provider (considering the deal size and Transtema’s history, we believe it must be Ericsson) and an EV-charging and home battery deal with Tibber. Combined with other deals (such as the pan-Nordic with GlobalConnect), we believe Transtema will experience a gradual improvement in growth momentum in H2 2024 and 2025.

New Base Case SEK27 (29)

We decreased our Base Case from SEK29 to SEK27 based on the estimate revisions - we believe our previous expectations on the Norway market likely were too optimistic. However, our positive view is retained, and we believe the worst is behind Transtema. The company is trading at 5.6x EBITA 2025e. Although we expect significant margin improvements compared to R12m numbers, our 5.2% EBITA margin assumption remains below the company’s 7% target.

Key financials

SEKm20232024e2025e2026e2027e
Revenues2,692.72,348.22,535.92,687.92,795.3
Revenue Growth9.0%-12.8%8.0%6.0%4.0%
EBITDA191.1179.0236.5248.1257.4
EBIT58.651.5106.5119.8128.4
EBIT Margin2.2%2.2%4.2%4.5%4.6%
Net Income171.919.774.584.991.6
EV/Sales0.30.40.30.20.2
EV/EBIT12.616.47.05.34.1

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.